Company Overview and News
UK-based energy services company TechnipFMC today said it has been awarded a contract for building one of the units at the Visakhapatnam refinery expansion project of state-owned Hindustan Petroleum Corporation Ltd (HPCL). The firm said it has been awarded a "substantial contract" for a grassroots hydrogen generation unit (HGU) at the refinery. It, however, did not disclose the value of the contract.
With an aim to ensure that right quantity and quality of fuel is dispensed at petrol stations, oil marketing company HPCL would automate all its petrol outlets by December, a top company official said here today.
Share prices of oil marketing and aviation companies rallied 4-6 percent intraday on Thursday following the sharp correction in crude oil prices in the international markets.
IOC INDIGO BPCL 500547 BRQPY 532617 HINDPETRO JETAIRWAYS 530965 500104 539448
Reliance Industries (RIL), Aegis Logistics, GAIL and Gujarat Gas rallied 2-4 percent intraday on Tuesday as the bidding for the ninth round of City Gas Distribution Scheme closes later today.
IOC 500325 BPCL 500547 RELIANCE 539336 AEGISLOG 530965 532514 IGL GUJGAS BRQPY RIGD GAILY 500003 HINDPETRO GAILF 500104 RLNIY
Mumbai: State-owned fuel marketers are pushing back against a regulatory suggestion to allow Reliance Industries Ltd (RIL) to use their pipelines to sell jet fuel at the Mumbai airport.
IOC 500325 BPCL 500547 BRQPY RELIANCE RIGD HINDPETRO 530965 500104 RLNIY
New Delhi : The board of state-owned Oil and Natural Gas Corp (ONGC) has given in-principle approval for exploring options for a restructuring of the group firms including the merger of subsidiaries MRPL and HPCL.
PQRTY HINDPETRO 500104 PETRONET 532522
A fall in small- and mid-cap stocks, set off by US President Donald Trump’s trade war mongering, in February that turned into a crash in June has put market traders firmly on the backfoot leading to a sharp decline in volumes.
IOC HINDPETRO 530965 500104
The Nifty and the Sensex are trading on a positive note this Tuesday afternoon after a flat morning session with the Nifty up 35 points at 10,797 and the Sensex is trading higher by 120 points at 35,591.
GRASIM 500408 500325 BRTQY JISLJALEQS ICLQY UCLQY 532480 BJJQY 500570 BRITANNIA CLNDY RLNIY ASHOKLEY SBAZ 500219 GRSJY BPCL TVSMOTOR UNITDSPR ALBK APOLLOTYRE AYRQY 530005 532822 517334 ULTRACEMCO AKLD 532432 BAJFINANCE BATAINDIA BRQPY UQNTY 500300 534809 HINDPETRO PCJEWELLER 500104 COALINDIA AKLS ABBOTINDIA 500825 500547 PQRTY RELIANCE PUNJLLOYD 512573 532538 533155 BHRQY NAUKRI JUBLFOOD 533278 532777 532343 MOZTY 532461 RIGD JBLWY 500477 INDIACEM BHARTIARTL TATAMOTORS 500034 570004 UBNC HINDALCO AVANTI 500877 UCLQF PETRONET 532522 532454 HNDNF GRSXY PNJZY 532693 MOTHERSUMI JISLDVREQS IDEA TATAELXSI PNB 500488 500043 500440 TTM
New Delhi : Boards of Hindustan Petroleum Corp and Mangalore Refinery and Petrochemicals may approve the merger of their companies in about two months, Oil and Natural Gas Corp Chairman and Managing Director Shashi Shankar said.
New Delhi : Abu Dhabi National Oil Company (Adnoc) on Monday signed an initial pact to take a stake in the planned $44-billion refinery in Maharashtra, joining Saudi Aramco which is looking at the project as a vehicle to enter India’s entire energy “value chain” including fuel retailing.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104
The broader indices including the Nifty and the Sensex are trading on a flat to positive note this Tuesday morning with the Nifty up 2 points at 10,765 and the Sensex is trading higher by 12 points at 35,475.
500408 FEDA JISLJALEQS ASIANPAINT UCLQY FEDS BJJQY 500570 FEDERALBNK CLNDY SBAZ 500219 TVSMOTOR 524804 FDBAY APOLLOTYRE AYRQY 530005 517334 ULTRACEMCO JSWSTEEL BAJAJFINSV BAJFINANCE BATAINDIA KOTAKBANK HINDPETRO 500104 COALINDIA ABBOTINDIA 500820 AUROPHARMA 500469 500228 PUNJLLOYD 512573 532978 532538 NAUKRI 533278 532777 532343 MOZTY 532461 INDIACEM TATAMOTORS 500034 570004 UBNC AVANTI KMBKY 500877 UCLQF PNJZY 532693 MOTHERSUMI JISLDVREQS ARBQY TATAELXSI PNB 500488 500247 500043 TTM
Benchmark indices ended at day's low with Nifty slipped below 10,800 and Sensex fell over 200 points as selling pressure seen in major banking, pharma and metal names.
IOC 500325 BPCL 500547 RELIANCE 530965 521070 BRQPY RIGD ALOKTEXT HINDPETRO 500104 RLNIY
The broader indices including the Nifty and the Sensex are trading on a negative note this Monday afternoon with the Nifty down 23 points at 10,798 and the Sensex is trading lower by 83 points at 35,606.
500325 533096 UBL 532714 JISLJALEQS ICLQY SYNDIBANK 532321 BJJQY MS 500570 EICHERMOT RLNIY ASHOKLEY 500219 BPCL 532827 UNITDSPR 532822 517334 ULTRACEMCO 500182 532432 500183 AXBA 532276 BAJAJFINSV BRQPY HINDPETRO 500104 COALINDIA ANDHRABANK DB 500547 532418 532538 AMARAJABAT 505200 AXISBANK RIGD JBLWY INFRATEL HEROMOTOCO TATAMOTORS 500034 INDIGO UBHOLDINGS UNBWY CDLYY 539448 AXBKY ICICIBANK HRTQY TTM PAGEIND 500008 MS.PRE MS.PRF MS.PRG HFCL MS.PRA 532478 CADILAHC ARJQY 534816 UCLQY 532480 CUMMINSIND 500493 CLNDY BHARATFORG SBAZ PGDQY TVSMOTOR AXB ALBK AKLD BAJFINANCE MS.PRI MS.PRK UQNTY 507458 AKLS ABBOTINDIA BHRYY RELIANCE 532978 533155 JUBLFOOD 533278 532215 532343 CMQMY MOZTY 532461 500477 KEC 570004 UBNC ECQRY IBN UCLQF 500480 PNJZY MOTHERSUMI 532174 JISLDVREQS IDEA PNB 500488 ADANIPOWER
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...